Addex Therapeutics Ltd. (ADXN)
6.54
+0.14
(+2.19%)
USD |
NASDAQ |
Jun 03, 16:00
6.54
0.00 (0.00%)
After-Hours: 19:59
Addex Therapeutics EPS Diluted (Quarterly) : -2.339 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 1.654 |
| Roche Holding AG | -- |
| Oculis Holding AG | -0.625 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.294M |
| Revenue (Quarterly) | 0.0198M |
| Total Expenses (Quarterly) | 2.314M |
| Enterprise Value | 6.077M |
| Gross Profit Margin (Quarterly) | 86.87% |
| Profit Margin (Quarterly) | -11.59K% |
| Earnings Yield | -139.1% |
| Normalized Earnings Yield | -139.07 |